Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Invest in UnitedHealth Group, not Eli Lilly: Good Buy or Goodbye
In This Article:
In the latest Good Buy or Goodbye, Regan Capital chief investment officer Skyler Weinand joins Market Domination host Julie Hyman to break down which stock is a good buy and what stock should be avoided.
Weinand recommends investing in UnitedHealth Group (UNH), as the company is trading at an attractive P/E ratio. He also recommends avoiding Eli Lilly (LLY), as its tremendous revenue growth is hard to repeat.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
Related Videos
Terms and Privacy Policy